Page last updated: 2024-11-04

sotalol and Body Weight, Fetal

sotalol has been researched along with Body Weight, Fetal in 1 studies

Sotalol: An adrenergic beta-antagonist that is used in the treatment of life-threatening arrhythmias.
sotalol : A sulfonamide that is N-phenylmethanesulfonamide in which the phenyl group is substituted at position 4 by a 1-hydroxy-2-(isopropylamino)ethyl group. It has both beta-adrenoreceptor blocking (Vaughan Williams Class II) and cardiac action potential duration prolongation (Vaughan Williams Class III) antiarrhythmic properties. It is used (usually as the hydrochloride salt) for the management of ventricular and supraventricular arrhythmias.

Research Excerpts

ExcerptRelevanceReference
"Sotalol is a beta-adrenoceptor blocking drug which also has class III antiarrhythmic properties via Ikr channel blockade."1.31Developmental toxicity in the pregnant rabbit by the class III antiarrhythmic drug sotalol. ( Danielsson, BR; Sköld, AC, 2001)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Sköld, AC1
Danielsson, BR1

Other Studies

1 other study available for sotalol and Body Weight, Fetal

ArticleYear
Developmental toxicity in the pregnant rabbit by the class III antiarrhythmic drug sotalol.
    Pharmacology & toxicology, 2001, Volume: 88, Issue:1

    Topics: Animals; Anti-Arrhythmia Agents; Area Under Curve; Embryo Loss; Embryonic and Fetal Development; Fem

2001